Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy
- 20 November 2007
- journal article
- consensus statement-update
- Published by Springer Nature in Diabetologia
- Vol. 51 (1) , 8-11
- https://doi.org/10.1007/s00125-007-0873-z
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Long-term Risk of Cardiovascular Events With RosiglitazoneJAMA, 2007
- Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes MellitusJAMA, 2007
- Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trialsThe Lancet, 2007
- Thiazolidinediones and Heart FailureDiabetes Care, 2007
- Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim AnalysisNew England Journal of Medicine, 2007
- Rosiglitazone — Continued Uncertainty about SafetyNew England Journal of Medicine, 2007
- Rosiglitazone and Cardiotoxicity — Weighing the EvidenceNew England Journal of Medicine, 2007
- The Record on Rosiglitazone and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- Rosiglitazone and Cardiovascular RiskNew England Journal of Medicine, 2007
- Thiazolidinedione Use and Bone Loss in Older Diabetic AdultsJournal of Clinical Endocrinology & Metabolism, 2006